Literature DB >> 24776847

Corticotropin-releasing hormone receptors mediate apoptosis via cytosolic calcium-dependent phospholipase A₂ and migration in prostate cancer cell RM-1.

Lai Jin1, Chuanhua Li, Rong Li, Zongxing Sun, Xianjun Fang, Shengnan Li.   

Abstract

Peripheral corticotropin-releasing hormone receptors (CRHRs) are G protein-coupled receptors that play different roles depending on tissue types. Previously, we discovered the mechanism of CRHR-mediated apoptosis of mouse prostate cancer cell line (RM-1) to be a change of Bcl-2:Bax ratio, and CRH was found to inhibit transforming growth factor β migration of breast cancer cells via CRHRs. In the present study, we investigated cytosolic calcium-dependent phospholipase A2 (cPLA2) bridging CRHR activations and Bcl-2:Bax ratio and the effect of CRHR activation on cell migration. Silencing of cPLA2 attenuated a CRHR1 agonist, CRH-induced apoptosis, and the decrease of the Bcl-2:Bax ratio, whereas silencing of cPLA2 aggravated CRHR2 agonist, Urocortin 2 (Ucn2)-inhibited apoptosis, and the increase of the Bcl-2:Bax ratio. CRH in a time- and concentration-dependent manner increased cPLA2 expression mainly through interleukin 1β (IL1β) upregulation. Ucn2 decreased cPLA2 expression through neither tumor necrosis factor α nor IL1β. CRH-suppressed decay of cPLA2 mRNA and Ucn2 merely suppressed its production. Overexpression of CRHR1 or CRHR2 in HEK293 cells correspondingly upregulated or downregulated cPLA2 expression after CRH or Ucn2 stimulation respectively. In addition, both CRH and Ucn2 induced migration of RM-1 cells. Our observation not only established a relationship between CRHRs and cell migration but also for the first time, to our knowledge, demonstrated that cPLA2 participates in CRHR1-induced apoptosis and CRHR2-inhibited apoptosis.

Entities:  

Keywords:  CRHR1; CRHR2; apoptosis; cPLA2; migration

Mesh:

Substances:

Year:  2014        PMID: 24776847     DOI: 10.1530/JME-13-0270

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  5 in total

1.  Pituitary corticotroph identity and receptor-mediated signaling: a transcriptomics perspective.

Authors:  Stanko S Stojilkovic; Rafael M Previde; Arthur S Sherman; Patrick A Fletcher
Journal:  Curr Opin Endocr Metab Res       Date:  2022-06-09

2.  Urocortin-1 Is Chondroprotective in Response to Acute Cartilage Injury via Modulation of Piezo1.

Authors:  Rebecca C Jones; Kevin M Lawrence; Scott M Higgins; Stephen M Richardson; Paul A Townsend
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

3.  Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis.

Authors:  Jill M Hoffman; Stavroula Baritaki; Jonathan J Ruiz; Aristea Sideri; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2015-11-18       Impact factor: 4.307

4.  CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.

Authors:  Charalabos Pothoulakis; Monica Torre-Rojas; Marco A Duran-Padilla; Jonathan Gevorkian; Odysseas Zoras; Emmanuel Chrysos; George Chalkiadakis; Stavroula Baritaki
Journal:  Int J Cancer       Date:  2017-10-12       Impact factor: 7.316

5.  Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling.

Authors:  Jorge A Rodriguez; Sara Huerta-Yepez; Ivy Ka Man Law; Guillermina J Baay-Guzman; Belen Tirado-Rodriguez; Jill M Hoffman; Dimitrios Iliopoulos; Daniel W Hommes; Hein W Verspaget; Lin Chang; Charalabos Pothoulakis; Stavroula Baritaki
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.